Ameriprise’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBPO
HA
YCMGA
MCP
PCM
Ameriprise's CBPO Position: Q2 2020 in Review
Ameriprise sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2020, closing a stake of 2,273 shares — an estimated $246K sold.
Ameriprise first reported a position in CBPO in Q2 2014 and held it in 15 quarters. The position peaked at $26.6M in Q3 2015. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2020.
- Ameriprise reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
- Ameriprise sold 2,273 China Biologic Products Holdings, Inc. shares in Q2 2020, an estimated $246K.
- Ameriprise first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 15 quarters.
- Ameriprise's China Biologic Products Holdings, Inc. position peaked at $26.6M in Q3 2015.
- 91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2020.
Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.